APA (7th ed.) Citation

Weyer, C., Tataranni, P. A., Snitker, S., E Danforth, J., & Ravussin, E. (1998). Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes (New York, N.Y.), 47(10), 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555

Chicago Style (17th ed.) Citation

Weyer, C., P A. Tataranni, S. Snitker, Jr E Danforth, and E. Ravussin. "Increase in Insulin Action and Fat Oxidation After Treatment with CL 316,243, a Highly Selective Beta3-adrenoceptor Agonist in Humans." Diabetes (New York, N.Y.) 47, no. 10 (1998): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555.

MLA (9th ed.) Citation

Weyer, C., et al. "Increase in Insulin Action and Fat Oxidation After Treatment with CL 316,243, a Highly Selective Beta3-adrenoceptor Agonist in Humans." Diabetes (New York, N.Y.), vol. 47, no. 10, 1998, pp. 1555-1561, https://doi.org/10.2337/diabetes.47.10.1555.